CAR-T cell therapy for diffuse large B-cell lymphoma, illustration 插畫檔
Illustration showing chimeric antigen receptor (CAR) T cells (blue) being used to treat diffuse large B-cell lymphoma (DLBCL) cells (purple). DLBCL is a common type of non-Hodgkin lymphoma, or cancer of the lymphatic system. It affects B lymphocytes, a white blood cell that produces antibodies to fight against infection. DLBCL normally develops in the lymph nodes causing uncontrollable growth of the B lymphocytes. It is typically fast-growing, and requires combined chemotherapy and immunotherapy. CAR-T therapy is a type of immunotherapy that genetically modifies a patient's own T cells, another form of white blood cell, to recognise and destroy cancer cells
購買授權
所有免版稅授權包含全球使用權限、全面的法律保障，定價簡單並享有計量折扣。
HK$2,250.00
HKD
Getty ImagesCart Cell Therapy For Diffuse Large Bcell Lymphoma Illustration, 插圖檔
從 Getty Images 下載優越而真實的CAR-T cell therapy for diffuse large B-cell lymphoma, illustration插畫檔。在我們廣泛多元的視覺內容目錄中，探索類似的高解像度插畫檔。Product #:2167928107
從 Getty Images 下載優越而真實的CAR-T cell therapy for diffuse large B-cell lymphoma, illustration插畫檔。在我們廣泛多元的視覺內容目錄中，探索類似的高解像度插畫檔。Product #:2167928107HK$2,250HK$400
Getty Images
In stock詳情
Getty Images 上的每份視覺內容，都是憑藉人類的專業、創意和智慧所精心打造。我們的素材庫不接受 AI 生成視覺內容。